Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alex Sapir Insider Profile
4 Followers
Alex Sapir, President & CEO, Director at Dova Pharmaceuticals, holds 193.36K shares in Fulcrum Therapeutics (Ticker: FULC), holds 3.75K shares in Phasebio Pharmaceuticals (Ticker: PHASQ), holds 68.61K shares in Dova Pharmaceuticals (Ticker: DOVA).
Alex Sapir Dova Pharmaceuticals (DOVA)President & CEO, Director
Dova Pharmaceuticals (DOVA)
President & CEO, Director
Ranked #82,024 out of 99,335 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-49.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Alex Sapir holds in companies
Most Profitable Insider Trade
Stock:
Dova Pharmaceuticals
(DOVA)
(DOVA)
Rating:Informative Buy
Date:Aug 15, 2018 - Aug 15, 2019
Return:-31.70%
The most profitable trade made by Alex Sapir
Alex Sapir's Trading History
Dova Pharmaceuticals
Aug 15, 2018
―
Informative Buy
495.41K
$1.92M
Phasebio Pharmaceuticals
May 19, 2023
―
Uninformative Buy
37.50
$90.00
Fulcrum Therapeutics
Jul 08, 2024
President & CEO, Director
Uninformative Buy
490.50K
$628.42K
List of latest transactions for each holding click on a transaction to see Alex Sapir's performance on stock
You May Also Like
Alex Sapir insider profile FAQ
What is the percentage of profitable transactions made by Alex Sapir?
The percentage of profitable transactions made by Alex Sapir is 0%.
What is the average return per transaction made by Alex Sapir?
The average return per transaction made by Alex Sapir is -49.90%.
What stocks does Alex Sapir hold?
Alex Sapir holds: DOVA, PHASQ, FULC stocks.
What was Alex Sapir’s latest transaction?
Alex Sapir latest transaction was an Uninformative Buy of $490.50K.
What was Alex Sapir's most profitable transaction?
Alex Sapir’s most profitable transaction was an Informative Buy of DOVA stock on August 15, 2018. The return on the trade was -31.70%.
What is Alex Sapir's role in Dova Pharmaceuticals?
Alex Sapir's role in Dova Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.